SUNNYVALE, Calif., Aug. 25 Avantis Medical Systems, Inc.announced today that it has appointed medical device industry experts ScottDodson as President and Chief Executive Officer (CEO), and Larry Tannenbaum asSenior Vice President and Chief Financial Officer (CFO). Both executives willassume key roles with the Avantis management team.
"We are pleased to announce this new executive leadership team forAvantis," said Fred Seddiqui, founder and chairman of Avantis. "Scott wasselected for his proven expertise in growing emerging companies and bringingnew products to market. He will be instrumental in all factors of ourcommercialization, through research, manufacturing, and distribution. Larrybrings extensive experience in managing growing companies and fundingexpansions."
Mr. Dodson is an accomplished medical device executive with a 20 yearcareer of increasing responsibility, leading large global teams for worldclass companies. From 1992 - 2006, Dodson was with Boston Scientific in itsUrology, Endoscopy and International Business units, also serving from2004 - 2006 as Vice President of Global Marketing in the company's Endoscopybusiness unit. From 2006 - 2008, Dodson was President of the Orthopedicbusiness for Orthofix, Inc., where he managed a large, cross-functional globalteam. Dodson earned his bachelor's degree in management from IndianaUniversity, and has completed executive programs at Columbia University,Babson College, and the American Management Association.
"Avantis offers physicians a superior visualization system that will leadto early cancer detection, reduced miss rates and disease prevention," saidDodson. "I am honored to be joining at such an exciting time in the company'shistory."
Dodson discussed Tannenbaum's hire as Chief Financial Officer and SeniorVice President. "Larry brings an impressive record in medical devicestart-ups and has been instrumental in positioning a number of companies foracquisition and/or an initial public offering. He has been directly involvedin developing, acquiring, and/or selling six companies, raising over $200million and negotiating transactions up to $400 million."
Mr. Tannenbaum's career in finance spans over 30 years. Most recently heserved in executive positions at Iridex as Senior Vice President and ChiefBusiness Officer, as well as Chief Financial Officer. Prior to Iridex,Tannenbaum also worked in senior management positions for LJL Biosystems,Arthrocare diabetes start-up Metrika (now Bayer Diagnostics), drugmanufacturer Sinogen, and Target Therapeutics (now Boston Scientific). He hasalso served as a lecturer at the Innovation Program for Stanford Universityfor the past six years. He graduated summa cum laude from Arizona StateUniversity and earned his MBA in finance from the University of Utah.
"In Avantis, I see a company poised to leverage its market position toachieve commercial success, and I am proud to be part of the team planning forthe company's future success," said Tannenbaum.
Avantis Medical Systems, Inc. is a visualization technology companyfocused on delivering cost effective solutions for the improved detection andprevention of cancers of the gastrointestinal (GI) tract.
The seasoned Avantis team is developing solutions for the limitationsassociated with today's technologies that are used to screen, assess and treatcancer throughout the alimentary tract and the body. Avantis has an extensiveportfolio of patents covering innovative devices based on the convergenttechnologies of micro-chips, enhanced video processing and catheter baseddelivery systems. For more information, visit http://www.avantismedical.com.
SOURCE Avantis Medical Systems, Inc.